Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp

IART

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.18B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Integra Lifesciences Holdings CorpIntegra Lifesciences Holdings Corp-165.1--1%0.82
$20.50

Target Price by Analysts

29.1% upsideIntegra Lifesciences Holdings Target Price DetailsTarget Price
$28.35

Current Fair Value

78.5% upside

Undervalued by 78.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.18 Billion
Enterprise Value$3.02 Billion
Dividend Yield$- (-)
Earnings per Share$-6.73
Beta1.21
Outstanding Shares78,168,000

Return

Return on Equity-0.69%ROE
Return on Assets-0.20%
Return on Invested Capital3.32%

Valuation & Multiples

P/E Ratio-165.08P/E Ratio
PEG163.56PEG
Price to Sales0.76Price to Sales
Price to Book Ratio1.22Price to Book Ratio
Enterprise Value to Revenue1.83
Enterprise Value to EBIT28.08
Enterprise Value to Net Income-418
Total Debt to Enterprise0.68
Debt to Equity1.95Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 30, 2026
EPS Estimate
$0.48
Average shareholder expectation
Revenue Estimate
$417.62 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 29, 2026
EPS Estimate
$0.56
Average shareholder expectation
Revenue Estimate
$416.30 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %95.57%▼ 1.63%
Total Invested$1.34B▲ 90.33%
Investors Holding213▲ 11.00%

ESG Score

No data

About Integra Lifesciences Holdings Corp

CEO: Peter Arduini